Related Experiment Video
Updated: Jun 19, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Costs of dyslipidemia
Hanna Zowall1, Steven A Grover
1Centre for the Analysis of Cost-Effective Care and the Divisions of General Internal Medicine and Clinical Epidemiology, The Montreal General Hospital, Department of Medicine, McGill University, Montreal, Quebec, Canada. hanna.zowall@mail.mcgill.ca
Statins are cost-effective for preventing cardiovascular disease, especially for secondary prevention and high-risk individuals. Treatment guidelines should balance cost-effectiveness with population costs and treatment rates.
Area of Science:
- Cardiology
- Pharmacoeconomics
Background:
- Dyslipidemia is a significant risk factor for cardiovascular disease (CVD).
- Current lipid-lowering therapies, primarily statins, are widely used.
- Understanding treatment effectiveness, costs, and healthcare implications is crucial.
Purpose of the Study:
- To discuss available dyslipidemia therapies, focusing on statins.
- To evaluate the cost-effectiveness of statin therapy for CVD prevention.
- To analyze healthcare implications and inform clinical guideline development.
Main Methods:
- Review of current lipid-lowering therapies, emphasizing statins.
- Analysis of cost-effectiveness data for statin therapy in primary and secondary CVD prevention.
- Consideration of factors influencing cost-effectiveness, such as drug costs and patient risk.
Main Results:
- Statin therapy is generally cost-effective for secondary CVD prevention.
- Statin therapy is also cost-effective for primary prevention in individuals with additional risk factors.
- Drug costs and absolute cardiovascular event risk are key determinants of cost-effectiveness.
Conclusions:
- Statin therapy represents a cost-effective approach to managing dyslipidemia and preventing CVD.
- Clinical guidelines must integrate cost-effectiveness, population treatment rates, and overall healthcare costs.
- Future strategies should optimize treatment based on individual risk and economic factors.
Related Concept Videos
Lipids: Dietary Sources and Requirements
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cholesterol: Significance and Regulation
Considering cholesterol and...